Ressources numériques en sciences humaines et sociales OpenEdition Nos plateformes OpenEdition Books OpenEdition Journals Hypothèses Calenda Bibliothèques OpenEdition Freemium Suivez-nous

EMA – A Workshop on a tailored clinical approach in biosimilar development will be held the 22 September 2025

This Biosimilar Medicinal Products Working Party (BMWP) workshop takes place as part of the consultation process following the Committee for Medicinal Products for Human Use (CHMP)’s adoption of the draft reflection paper on a tailored clinical approach in biosimilar development.

The event supports the implementation of the BMWP’s workplan and aligns with broader efforts to facilitate proportionate, science-based regulatory pathways for biosimilars. It takes place during the public consultation period, which runs until 30 September 2025.

The workshop brings together EU and non-EU regulators, international partners, patient and healthcare professional organisations, academia, and industry stakeholders to discuss the proposed approach and provide feedback on the draft document.

More information on the EMA Website.


OpenEdition vous propose de citer ce billet de la manière suivante :
vroby (20 septembre 2025). EMA – A Workshop on a tailored clinical approach in biosimilar development will be held the 22 September 2025. ELSIBI. Consulté le 19 janvier 2026 à l’adresse https://doi.org/10.58079/14pwy


Vous aimerez aussi...

Laisser un commentaire

Votre adresse e-mail ne sera pas publiée. Les champs obligatoires sont indiqués avec *

This site uses Akismet to reduce spam. Learn how your comment data is processed.